News Digest / Income Statements / Xylem Inc. Reports Q1 2025 Earnings: Revenue Up, Orders Down Amid Restructuring Costs

Xylem Inc. Reports Q1 2025 Earnings: Revenue Up, Orders Down Amid Restructuring Costs

StockInvest.us
12:01pm, Tuesday, Apr 29, 2025
Illustration by StockInvest.us

Xylem Inc. (NYSE: XYL) has released its financial results for the first quarter of 2025, providing insights into its operational performance and financial status.

Key Highlights:

  • Revenue: $2,069 million, up 1.8% from $2,033 million in Q1 2024.
  • Net Income: $169 million, representing a growth of 9.2% year-over-year.
  • Earnings Per Share (EPS): $0.69, an increase of 9.5% compared to $0.63 in the same quarter last year.
  • Adjusted EBITDA: $423 million with an adjusted EBITDA margin of 20.4%, up 120 basis points from 19.2% in the prior year.
  • Orders: Totaling $2,158 million, down 3.9% year-over-year.

Positive Aspects:

  • Organic Growth: Driven mainly by strong performance in the Measurement and Control Solutions segment, with an organic increase of 3.3% or $67 million.
  • Gross Profit: Increased to $768 million from $752 million, reflecting efficient cost management.
  • Decreased Interest Expense: Interest costs fell to $8 million from $14 million, enhancing profitability.
  • Strong Cash Position: Cash and cash equivalents at $1,059 million as of March 31, 2025.

Negative Aspects:

  • Decline in Orders: Orders decreased by 3.9% overall, indicating a potential slowdown in demand.
  • Increased Restructuring Costs: Charges increased to $21 million from $10 million, indicating a significant expense to streamline operations.
  • Loss on Sale of Businesses: The company recorded a $10 million loss associated with divestitures.
  • Cash Flow from Operations: Only $33 million, a steep decline from $89 million in the previous year, indicating pressure on operational cash generation.

Financial Overview:

  • Total Assets: $16,559 million, slightly up from $16,493 million at the end of the previous year.
  • Total Liabilities: Reduced to $5,505 million from $5,611 million, indicating improved financial health.
  • Stockholders’ Equity: Increased to $10,822 million, demonstrating strong retention of earnings.

Overall, Xylem Inc. demonstrates resilience in its revenue growth and operational efficiency despite facing challenges such as declining orders and restructuring costs. The positive EPS growth and improved liquidity position suggest stability moving forward.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.